Back to search

Article

Enpp1 ameliorates NAFLD by regulating hepatocyte lipid metabolism through the AMPK/PPARα signaling pathway

2024-10-17

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Non-alcoholic fatty liver disease (NAFLD) has become the leading chronic liver disease worldwide, and there are no approved pharmacotherapies to treat this disease. Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) has been found to be related to insulin resistance and lipid accumulation. However, the role and mechanism of Enpp1 in the development of NAF...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
737c165a-edfd-5421-954b-5d69de3757f3
DOI
10.21203/rs.3.rs-4877420/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enpp1 ameliorates NAFLD by regulating hepatocyte lipid metabolism through the AMPK/PPARα signaling pathwayDOI 10.21203/rs.3.rs-4877420/v1
LncNONMMUG027912 alleviates lipid accumulation through AMPKα/mTOR/SREBP1C axis in nonalcoholic fatty liverSemantic proximity
Metformin's Effect on Non-Alcoholic Fatty Liver Disease through the miR-200a-5p and AMPK/SERCA2b PathwaySemantic proximity
Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARsSemantic proximity
GCN5 drives NAFLD progression through LXRα/SREBP1c signaling pathway-mediated de novo lipogenesisSemantic proximity
PPARα-ERRα crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progressionSemantic proximity
Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implicationsSemantic proximity
The role of C5aR1-mediated hepatic macrophage efferocytosis in NASHSemantic proximity
Fat Mass and Obesity–Associated Protein Promotes Liver Steatosis By Targeting PPARαSemantic proximity
Identification of metabolic biomarkers associated with nonalcoholic fatty liver diseaseSemantic proximity
The pharmacodynamic and differential gene expression analysis of PPAR α/δ agonist GFT505 in CDAHFD-induced NASH modelSemantic proximity
Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in nonalcoholic fatty liver diseaseSemantic proximity
Regulation of fatty acid oxidation by liraglutide via SIRT1 in hepatocytes: A mechanistic studySemantic proximity
Select a neighboring publication to make it the new centre.